Rozpocznij
ABBVIE INCABBVIE INCABBVIE INC

ABBVIE INC

Brak transakcji
Zobacz na super wykresach
Przegląd Finanse Pomysły Dyskusje Dane techniczne Prognoza Sezonowość
Obligacje

Obligacje 4AB

Poniżej znajduje się lista obligacji korporacyjnych ABBVIE INC. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol
YTM %
Wolumen
Cena %
Kupon %
Termin zapadalności
Kwota niezapłacona
Wartość nominalna
Min. kw. nominału
Emitent
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
6,57%600 K84,44%4,55%2035-03-15107,646 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6,56%15 K79,63%4,85%2044-06-1565,232 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
6,44%10 K79,20%4,75%2045-03-1553,51 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6,31%5 K80,72%4,63%2042-10-0167,493 M USD1 000,00 USD2 000,00 USDActavis, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,71%50 K89,00%3,20%2029-11-2162,515 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,62%16,154 M97,71%5,50%2064-03-151,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5,54%089,07%4,70%2045-05-142,7 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,53%156 K91,37%4,85%2044-06-151,008 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,52%15,452 M98,00%5,40%2054-03-153 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,50%43 K90,94%4,88%2048-11-141,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5,50%085,80%4,45%2046-05-142 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,49%100 K98,22%5,35%2044-03-15750 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,46%90 K90,75%4,75%2045-03-15827,091 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,44%200 K90,15%4,63%2042-10-01389,217 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5,43%1,115 M87,53%4,40%2042-11-062,599 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5,39%30,585 M82,91%4,25%2049-11-215,745 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5,36%3,78 M85,94%4,05%2039-11-214 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5,25%091,57%4,30%2036-05-141 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5,25%428 K94,31%4,55%2035-03-151,681 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5,20%094,24%4,50%2035-05-142,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
5,11%3,506 M99,52%5,05%2034-03-153 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,96%8,891 M99,93%4,95%2031-03-152 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,80%6,943 M92,82%3,20%2029-11-215,437 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4,79%2,34 M100,02%4,80%2029-03-152,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
AA5QDALLERGAN FNDG 15/25
4,76%099,06%3,80%2025-03-15130,225 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
4,75%096,53%2,95%2026-11-219,245 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4,67%1,083 M100,29%4,80%2027-03-152,25 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4,65%7,598 M98,54%4,25%2028-11-141,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4,64%097,92%3,20%2026-05-142 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4,59%1,678 M96,83%2,95%2026-11-213,991 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4,33%099,29%3,60%2025-05-143,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4,22%538 K99,59%3,80%2025-03-152,889 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
3,78%095,69%2,63%2028-11-1572,107 M EUR1 000,00 EUR100 000,00 EURAllergan Funding SCS
XXS162262122ALLERGAN FNDG 17/29
3,77%093,12%2,13%2029-06-0136,462 M EUR1 000,00 EUR100 000,00 EURAllergan Funding SCS
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3,07%0121,31%4,25%2049-11-214,95 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3,03%0126,76%4,75%2045-03-155 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2,96%0128,71%4,85%2044-06-15100 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABGABBVIE 19/31
2,89%089,58%1,25%2031-11-18650 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2,77%097,23%2,13%2029-06-01506,088 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2,75%099,53%2,63%2028-11-15427,793 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
ABBV5066461AbbVie Inc. 2.6% 21-NOV-2024
2,71%1,384 M99,89%2,60%2024-11-213,739 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
XS152090781ABBVIE 16/28
2,68%097,89%2,13%2028-11-17750 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2,52%094,87%0,75%2027-11-18750 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,01%0123,74%4,55%2035-03-151 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
1,63%0102,15%3,80%2025-03-151,268 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4911714AbbVie Inc. 2.6% 21-NOV-2024
−3,63%0106,34%2,60%2024-11-2110,86 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
———3,80%2025-03-15—1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4,40%2042-11-061,1 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.